HHS wants your hormone studies

HHS’s Agency for Healthcare Research and Quality released a notice that it’s looking for scientific information it can use in a systematic review titled “Improving the Management of Menopausal Symptoms in Perimenopausal and Early Postmenopausal Women.” 

Although this isn’t compounding specific, it drew our attention. Apparently AHRQ is planning to conduct just such a systematic review on managing menopausal symptoms in perimenopausal and early postmenopausal women, and it wants to be sure to get the best, latest info. It’s soliciting details of completed and ongoing studies related to the topic, including study design and methodology, and obviously outcomes and results.

Again, it’s not specific to compounding, but as compounding pharmacies are often at the forefront of providing customized hormone therapies for menopausal symptoms, the findings of this review could directly or indirectly impact practices and guidelines related to compounded treatments. 

If you have any of this kind of data to share (such as a meta-analysis), we urge you to submit it. You can read more information in the AHRQ PDF document, and send your study information by email to epc@ahrq.hhs.gov; reach out to Kelly Carper at 301-427-1656 or that same address if you have questions.

We’ll let you know what comes of this, of course.